Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.
about
Morphine for the treatment of pain in sickle cell diseaseHeme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factorCorrelation between the Lactate Dehydrogenase Levels with Laboratory Variables in the Clinical Severity of Sickle Cell Anemia in Congolese Patients.The acute phase inflammatory response to maximal exercise testing in children and young adults with sickle cell anaemia.Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen speciesHydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature.Coronary artery ectasia in atherosclerotic coronary artery disease, inflammatory disorders, and sickle cell disease.Therapeutic potential of endothelin receptor antagonism in kidney disease.Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.Elevated D-dimer levels in African Americans with sickle cell traitVascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease.Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.
P2860
Q28087296-E68B9E13-3C94-489C-A638-9747DEFAB2BDQ34019609-D8876E59-43ED-45E9-B4A4-1AD0ABDA4A1FQ35577509-A57683C0-A276-43F5-8C05-0CEC76D0EAC3Q36470656-683CBC57-782E-414B-82AD-46940B76A20CQ37084544-AB9C5752-1812-4837-B635-24184E41D51DQ38211494-D8A8FFA6-E12D-4538-A257-1088175D6A8FQ38353988-A34950CE-1658-4E28-B9D5-441924343DD3Q38678678-A4E4E410-EC5D-49A2-8DC0-85236E3EF952Q38847491-C2978521-D618-41B7-9940-240292B53BF4Q38859913-72E52661-1683-4630-83CD-FA3BFA1D6204Q40985507-2816FA07-6890-421F-AB6D-A02530C07882Q42821629-AEF400E1-BB6C-40EF-A92D-2B2DFD5390A4Q43150240-EDD6536A-8DAF-4BA2-8569-89BB85970EEBQ50459628-B9CC51CB-A3EA-4750-8982-915964AEFF5FQ55058563-7D2A13AE-82D2-4004-AB47-44248D3D7911
P2860
Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Endothelial activation and inf ...... ents with sickle cell disease.
@en
Endothelial activation and inf ...... ents with sickle cell disease.
@nl
type
label
Endothelial activation and inf ...... ents with sickle cell disease.
@en
Endothelial activation and inf ...... ents with sickle cell disease.
@nl
prefLabel
Endothelial activation and inf ...... ents with sickle cell disease.
@en
Endothelial activation and inf ...... ents with sickle cell disease.
@nl
P2093
P2860
P50
P1476
Endothelial activation and inf ...... cents with sickle cell disease
@en
P2093
A Taparkou
F Kanakoudi
M Athanassiou
V Garipidou
V Tzimouli
Zoe Dorothea Pana
P2860
P2888
P304
P356
10.1007/S12185-013-1392-Y
P577
2013-06-27T00:00:00Z